1476 J . Org. Chem., Vol. 61, No. 4, 1996
Chou and Fang
evaporation, and the residue was chromatographed on a silica
gel column by elution with MeOH/CH2Cl2 (1:9) to give crude
ester 7a contaminated with imidazole. The crude ester was
dissolved in CH2Cl2 (20 mL), IR-120 resin (acidic form) was
added, and the resulting mixture was stirred for 1 h. The
mixture was filtered, and the filtrate was concentrated to give
pure 7a (351 mg, 93%): oil; Rf 0.26 (MeOH/CH2Cl2 (1:9)); IR
(neat) 3200, 1730, 1063 cm-1; MS m/ z (rel intensity) 476 (10,
M+ + 1), 475 (1, M+), 339 (5), 159 (100), 138 (20), 106 (10), 91
(t), 33.47 (t), 35.95 (t), 38.05 (d), 45.84 (t), 53.91 (t), 55.23 (q),
61.83 (t), 62.43 (t), 66.33 (t), 70.70 (d), 78.54 (d), 82.24 (s),
113.66 (d, 2 C), 128.80 (d, 2 C), 128.95 (d), 130.22 (s), 132.75
(s), 159.03 (s), 173.44 (s), 198.60 (s); HRMS for C26H37NO6S2
calcd 523.2062, found 523.2060.
Cr oba r ba tin e Der iva tives 9a a n d 10a . Under an argon
atmosphere, a solution of thioester 8a (56 mg, 0.11 mmol) in
anhydrous THF (10 mL) was added dropwise over a period of
2 h to a refluxing THF (30 mL) solution containing 4-(di-
methylamino)pyridine (166 mg, 1.36 mmol) and silver(I)
trifluoroacetate (145 mg, 0.68 mmol). The resulting green
solution was heated at reflux for an additional 40 h, cooled,
and stirred at room temperature for 2 h. The mixture was
bubbled with H2S (prepared from FeS and dilute H2SO4) until
no more black precipitate appeared. The black precipitate was
filtered, the filtrate was concentrated and chromatographed
on a silica gel column by elution with MeOH/CH2Cl2 (1:9), Rf
0.37, to give dilactones 9a and 10a (24 mg, 55%, 1:1 ratio).
Two isomers were separated by HPLC. 9a : oil; tR 7.83 min
(MeOH/CH2Cl2 (2:8)); [R]26D ) +32.3° (c 1.12, CHCl3); IR (neat)
1731, 699 cm-1; MS m/ z (rel intensity) 385 (6, M+), 279 (32),
251 (35), 220 (23), 135 (52), 119 (100), 91 (28); 1H NMR (CDCl3)
1
(36); H NMR (CDCl3) δ 1.06 (d, J ) 6.8 Hz, 3 H), 1.51 (s, 3
H), 2.00-2.17 (m, 4 H), 2.76-2.97 (m, 5 H), 3.21-3.30 (m, 1
H), 3.43-3.58 (m, 2 H), 4.10 (br d, J ) 15.3 Hz, 1 H), 4.37-
4.44 (m, 2 H), 4.50-4.52 (m, 2 H), 4.65-4.90 (m, 2 H), 5.82
(br s, 1 H), 6.01 (d, J ) 10.1 Hz, 1 H), 7.22-7.38 (m, 5 H); 13
C
NMR (CDCl3) δ 14.28 (q), 18.87 (q), 24.71 (t), 29.30 (t), 29.86
(t), 35.71 (t), 41.93 (d), 53.26 (t), 61.36 (t), 61.72 (t), 66.10 (t),
70.10 (d), 77.96 (d), 82.09 (s), 126.74 (d, 3 C), 126.79 (d), 127.42
(s), 127.84 (d, 2 C), 132.84 (s), 133.40 (d), 138.42 (s), 172.85
(s); HRMS for C25H33NO4S2 calcd 475.1851, found 475.1842.
Retr on ecin e Ester of 2,3-Dim eth yl-4-(1,3-d ith ia n yl-
iden e)-2-[(4-m eth oxyben zyl)oxy]bu tan oic Acid (7b). Treat-
ment of imidazolide (()-6b (401 mg) with (+)-retronecine by
a procedure similar to that for 7a , after removal of residual
imidazole with IR-120 resin, gave ester 7b (484 mg, 100%):
1.10 (d, J ) 7.1 Hz, 3 H), 1.53 (s, 3 H), 1.92-2.15 (m, 2 H),
δ
2.02 (dd, J ) 16.6, 1.6 Hz, 1 H), 2.45 (ddq, J ) 10.1, 7.1, 1.6
Hz, 1 H), 2.72-2.79 (m, 1H), 3.03 (dd, J ) 16.6, 10.7 Hz, 1 H),
3.28 (ddd, J ) 8.9, 6.9, 2.0 Hz, 1 H), 3.50 (dd, J ) 20.3, 5.5
Hz, 1 H), 3.94 (dd, J ) 20.3, 1.9 Hz, 1 H), 4.34, 4.46 (AB
quartet, J ) 11.3 Hz, 2 H), 4.45-4.47 (m, 1 H), 4.43, 4.55 (AB
quartet, J ) 11.6 Hz, 2 H), 5.59 (ddd, J ) 5.2, 5.2, 1.8 Hz, 1
H), 5.88 (br d, J ) 1.9 Hz, 1H), 7.25-7.41 (m, 5 H); 13C NMR
(CDCl3) δ 16.10 (q), 20.37 (q), 33.17 (t), 37.24 (t), 38.75 (d),
54.18 (t), 59.27 (t), 61.13 (t), 66.97 (t), 72.54 (d), 78.64 (d), 80.83
(s), 127.36 (d, 3 C), 128.10 (d, 2 C), 132.40 (s), 134.94 (d), 138.89
(s), 173.08 (s), 174.19 (s); HRMS for C22H27NO2 calcd 385.1890,
found 385.1895. 10a : oil, tR 9.83 min (MeOH/CH2Cl2 (2:8));
oil; Rf 0.24 (MeOH/CH2Cl2 (1:9)); IR (neat) 3200, 1730 cm-1
;
MS m/ z (rel intensity) 506 (1, M+ + 1), 505 (0.1, M+), 367 (2),
1
232 (2), 159 (60), 132 (15), 121 (21); H NMR (CDCl3) δ 1.00
(d, J ) 6.7 Hz, 3 H), 1.46 (s, 3 H), 1.89-2.00 (m, 2 H), 2.05-
2.13 (m, 2 H), 2.71-2.90 (m, 5 H), 3.14-3.25 (m, 1 H), 3.42-
3.53 (m, 2 H), 3.76 (s, 3 H), 4.10 (br d, J ) 15.6 Hz, 1 H), 4.28-
4.35 (m, 2 H), 4.37-4.50 (m, 2 H), 4.65-4.85 (m, 2 H), 5.78
(br s, 1 H), 5.94 (d, J ) 10.1 Hz, 1 H), 6.86 (d, J ) 8.7 Hz, 2
H), 7.24 (d, J ) 8.7 Hz, 2 H); 13C NMR (75 MHz, CDCl3) δ
14.53 (q), 19.24 (q), 24.97 (t), 29.58 (t), 30.12 (t), 35.67 (t), 42.07
(d), 53.95 (t), 55.21 (q), 61.45 (t), 61.91 (t), 66.07 (t), 70.39 (d),
78.70 (d), 82.31 (s), 113.59 (d, 2 C), 127.35 (d), 127.65 (s), 128.76
(d, 2 C), 130.47 (s), 132.55 (s), 133.70 (d), 158.93 (s), 173.18
(s); HRMS for C26H35NO5S2 calcd 505.1957, found 505.1955.
[R]26 ) -41.5° (c 0.53, CHCl3); IR (neat) 1738, 699 cm-1; MS
D
m/ z (rel intensity) 385 (0.1, M+), 279 (8), 251 (35), 220 (10),
136 (40), 119 (60), 91 (28); 1H NMR (CDCl3) δ 1.03 (d, J ) 6.9
Hz, 3 H), 1.49 (s, 3 H), 2.00-2.11 (m, 2 H), 2.19 (dd, J ) 15.7,
3.2 Hz, 1 H), 2.45-2.65 (m, 2 H), 2.79 (dd, J ) 15.7, 11.1 Hz,
1 H), 3.19-3.30 (m, 1 H), 3.46 (dd, J ) 16.4, 5.6 Hz, 1 H), 3.97
(br d, J ) 16.4 Hz, 1 H), 4.38-4.44 (m, 1 H), 4.39, 5.11 (AB
quartet, J ) 11.4 Hz, 2 H), 4.40, 4.73 (AB quartet, J ) 11.1
Hz, 2 H), 5.08-5.14 (m, 1 H), 6.00 (br d, J ) 1.9 Hz, 1 H),
7.25-7.46 (m, 5 H); 13C NMR (CDCl3) δ 15.43 (q), 20.81 (q),
33.70 (t), 37.36 (t), 38.65 (d), 53.79 (t), 57.52 (t), 61.51 (t), 66.28
(t), 74.56 (d), 76.79 (d), 79.49 (s), 127.14 (d, 3 C), 128.16 (d, 2
C), 133.58 (s), 133.88 (d), 139.15 (s), 170.64 (s), 173.50 (s);
HRMS for C22H27NO2 calcd 385.1890, found 385.1895.
Retr on ecin e Ester of 2-(Ben zyloxy)-2,3-d im eth yl-4-
[[(3-m er ca p t op r op yl)su lfa n yl]ca r b on yl]b u t a n oic Acid
(8a ). To a stirring solution of 7a (321 mg, 0.68 mmol) in CH2-
Cl2 (20 mL) was added HCl (37%, 0.25 mL) at 25 °C; the
solution turned pink immediately. After 0.5 h, the solution
was concentrated by rotary evaporation, and the residue was
chromatographed on a silica gel column by elution with MeOH/
CH2Cl2 (1:9) to give thioester 8a (294 mg, 88%): oil; Rf 0.26
(MeOH/CH2Cl2 (1:9)); IR (neat) 3341, 1726 (ester), 1682
(thioester), 699 cm-1; MS (20 eV) m/ z (rel intensity) 493 (4,
M+), 386 (4), 369 (4), 278 (10), 200 (21), 138 (100), 113 (97);
1H NMR (CDCl3) δ 0.97 (d, J ) 6.5 Hz, 3 H), 1.46 (s, 3 H),
1.85 (quin, J ) 7.0 Hz, 2 H), 2.01-2.10 (m, 2 H), 2.40-2.70
(m, 2 H), 2.55 (t, J ) 7.0 Hz, 2 H), 2.79-2.99 (m, 2 H), 2.96 (t,
J ) 7.0 Hz, 2 H), 3.50-3.70 (m, 2 H), 4.21 (br d, J ) 15.4 Hz,
1 H), 4.50-4.62 (m, 4 H), 4.70, 4.81 (AB quartet, J ) 13.8 Hz,
2 H), 5.78 (br s, 1 H), 7.26-7.35 (m, 5 H); 13C NMR (CDCl3) δ
14.42 (q), 17.21 (q), 23.27 (t), 27.27 (t), 33.39 (t), 35.83 (t), 38.10
(d), 45.86 (t), 53.93 (t), 61.27 (t), 61.40 (t), 66.57 (t), 70.21 (d),
78.53 (d), 82.44 (s), 126.73 (d, 3 C), 127.13 (d), 128.26 (d, 2 C),
Cr oba r ba tin e Der iva tives 9b a n d 10b. Thioester 8b (73
mg) was treated with silver trifluoroacetate and 4-(dimethyl-
amino)pyridine by a procedure similar to that for 9a /10a to
give dilactones 9b and 10b (1:1; 39 mg, 67%). 9b: tR 14.5 min
(MeOH/CH2Cl2 (1:9)); [R]23D ) +39.0° (c 0.20, CHCl3); IR (neat)
1735, 1247 cm-1; MS m/ z (rel intensity) 416 (8, M+ + 1), 415
(1, M+), 294 (4), 279 (19), 250 (41), 220 (23), 136 (47), 121 (100);
1H NMR (CDCl3) δ 1.06 (d, J ) 7.0 Hz, 3 H), 1.50 (s, 3 H),
1.93-2.07 (m, 2 H), 1.97 (dd, J ) 16.5, 1.2 Hz, 1 H), 2.42 (ddq,
10.9, 7.0, 1.2 Hz, 1 H), 2.65-2.80 (m, 1 H), 2.99 (dd, J ) 10.5,
16.5 Hz, 1 H), 3.25 (ddd, J ) 8.8, 6.7, 2.2 Hz, 1 H), 3.49 (dd, J
) 16.6, 4.3 Hz, 1 H), 3.78 (s, 3 H), 3.93 (br d, J ) 16.6 Hz, 1
H), 4.24, 4.36 (AB quartet, J ) 10.7 Hz, 2 H), 4.34-4.45 (m, 1
H), 4.46, 4.62 (AB quqrtet, J ) 11.7 Hz, 2 H), 5.58 (ddd, J )
5.3, 5.3, 1.9 Hz, 1 H), 5.91 (br d, J ) 1.8 Hz, 1 H), 6.84 (d, J )
8.7 Hz, 2 H), 7.30 (d, J ) 8.7 Hz, 2 H); 13C NMR (CDCl3) δ
16.11 (q), 20.43 (q), 33.20 (t), 37.20 (t), 38.72 (d), 54.24 (t), 55.30
(q), 59.27 (t), 61.13 (t), 66.70 (t), 72.47 (d), 78.74 (d), 80.70 (s),
113.53 (d, 2 C), 128.90 (d, 2 C), 130.97 (s), 132.51 (s), 134.86
(d), 159.03 (s), 173.13 (s), 174.33 (s); HRMS for C23H29NO6 calcd
415.1995, found 415.2020. 10b: tR 16.3 min (MeOH/CH2Cl2
132.80 (s), 138.10 (s), 173.18 (s), 198.64 (s); HRMS for C25H35
NO5S2 calcd 493.1957, found 493.1968.
-
Retr on ecin e Ester of 2,3-Dim eth yl-4-[[(3-m er ca p to-
p r op yl)su lfa n yl]ca r bon yl]-2-[(4-m eth oxyben zyl)oxy]bu -
ta n oic Acid (8b). Ester 7b (784 mg) was treated with concd
HCl by a procedure similar to that for 8a to give thioester 8b
(432 mg, 53%): oil; IR (neat) 3358, 1723 (ester), 1675 (thioester)
cm-1; MS m/ z (rel intensity) 524 (2, M+ + 1), 523 (0.3, M+),
1
369 (1), 278 (2), 249 (3), 228 (4), 137 (25), 121 (100); H NMR
(300 MHz, CDCl3) δ 0.92 (d, J ) 6.7 Hz, 3 H), 1.41 (s, 3 H),
1.81 (quin, J ) 7.0 Hz, 2 H), 1.93-2.00 (m, 2 H), 2.38-2.60
(m, 2 H), 2.52 (t, J ) 7.0 Hz, 2 H), 2.76-2.85 (m, 2 H), 2.92 (t,
J ) 7.0 Hz, 2 H), 3.35-3.46 (m, 2 H), 3.76 (s, 3 H), 4.01 (br d,
J ) 15.6 Hz, 1 H), 4.25-4.40 (m, 4 H), 4.62-4.80 (m, 2 H),
5.81 (br s, 1 H), 6.83 (d, J ) 8.6 Hz, 2 H), 7.23 (d, J ) 8.6 Hz,
2 H); 13C NMR (CDCl3) δ 14.39 (q), 17.17 (q), 23.96 (t), 27.26
(1:9)); [R]23D -46.8° (c 0.47, CHCl3); IR (neat) 1735, 1246 cm-1
;
MS m/ z (rel intensity) 416 (5, M+ + 1), 415 (1, M+), 294 (2),
279 (10), 250 (27), 220 (13), 136 (29), 121 (100); 1H NMR
(CDCl3) δ 0.99 (d, J ) 7.0 Hz, 3 H), 1.46 (s, 3 H), 2.00-2.09